Hypoglycemic effects of brassinosteroid in diet-induced obese mice.

The prevalence of obesity is increasing globally, and obesity is a major risk factor for metabolic diseases such as type 2 diabetes. Previously, we reported that oral administration of homobrassinolide (HB) to healthy rats triggered a selective anabolic response that was associated with lower blood glucose. Therefore, the aim of this study was to evaluate the effects of HB administration on glucose metabolism, insulin sensitivity, body composition, and gluconeogenic gene expression profiles in liver of C57BL/6J high-fat diet-induced obese mice. Acute oral administration of 50-300 mg/kg HB to obese mice resulted in a dose-dependent decrease in fasting blood glucose within 3 h of treatment. Daily chronic administration of HB (50 mg/kg for 8 wk) ameliorated hyperglycemia and improved oral glucose tolerance associated with obesity without significantly affecting body weight or body composition. These changes were accompanied by lower expression of two key gluconeogenic enzymes, phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G-6-Pase), and increased phosphorylation of AMP-activated protein kinase in the liver and muscle tissue. In vitro, HB treatment (1-15 μM) inhibited cyclic AMP-stimulated but not dexamethasone-stimulated upregulation of PEPCK and G-6-Pase mRNA levels in H4IIE rat hepatoma cells. Among a series of brassinosteroid analogs related to HB, only homocastasterone decreased glucose production in cell culture significantly. These results indicate the antidiabetic effects of brassinosteroids and begin to elucidate their putative cellular targets both in vitro and in vivo.

[1]  W. G. Hill,et al.  Inbred lines of mice derived from long-term divergent selection on fat content and body weight , 1999, Mammalian Genome.

[2]  I. Raskin,et al.  Anabolic effect of plant brassinosteroid , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  I. Raskin,et al.  Akt-dependent anabolic activity of natural and synthetic brassinosteroids in rat skeletal muscle cells. , 2011, Journal of medicinal chemistry.

[4]  Ying Sun,et al.  Brassinosteroid signal transduction from cell-surface receptor kinases to nuclear transcription factors , 2009, Nature Cell Biology.

[5]  A. Gormand,et al.  Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. , 2009, American journal of physiology. Endocrinology and metabolism.

[6]  I. Raskin,et al.  20-Hydroxyecdysone decreases weight and hyperglycemia in a diet-induced obesity mice model. , 2009, American journal of physiology. Endocrinology and metabolism.

[7]  I. Raskin,et al.  Phytoecdysteroids increase protein synthesis in skeletal muscle cells. , 2008, Journal of agricultural and food chemistry.

[8]  In-kyu Lee,et al.  Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP , 2008, Diabetes.

[9]  A. Berra,et al.  The in vitro immunomodulatory activity of a synthetic brassinosteroid analogue would account for the improvement of herpetic stromal keratitis in mice , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  Miroslav Strnad,et al.  Anticancer and antiproliferative activity of natural brassinosteroids. , 2008, Phytochemistry.

[11]  Á. Márki,et al.  Phytoecdysteroids and anabolic-androgenic steroids--structure and effects on humans. , 2008, Current medicinal chemistry.

[12]  I. Raskin,et al.  Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line. , 2007, American journal of physiology. Endocrinology and metabolism.

[13]  C. Huard,et al.  Inhibition of Gluconeogenesis through Transcriptional Activation of EGR1 and DUSP4 by AMP-activated Kinase* , 2006, Journal of Biological Chemistry.

[14]  N. Ruderman,et al.  Metabolic Syndrome: Adenosine Monophosphate‐activated Protein Kinase and Malonyl Coenzyme A , 2006, Obesity.

[15]  M. Sajan,et al.  Insulin signalling downstream of protein kinase B is potentiated by 5′AMP-activated protein kinase in rat hearts in vivo , 2005, Diabetologia.

[16]  D. Allison,et al.  Antipsychotic drug-induced weight gain: development of an animal model , 2005, International Journal of Obesity.

[17]  C. Müssig,et al.  Brassinosteroid-Promoted Growth , 2005, Plant biology.

[18]  J. Ramirez,et al.  In vitro and in vivo antiherpetic activity of three new synthetic brassinosteroid analogues , 2004, Steroids.

[19]  Jingquan Yu,et al.  A role for brassinosteroids in the regulation of photosynthesis in Cucumis sativus. , 2004, Journal of experimental botany.

[20]  A. Tretyn,et al.  The chemical characteristic and distribution of brassinosteroids in plants. , 2003, Phytochemistry.

[21]  S. Fujioka,et al.  Biosynthesis and metabolism of brassinosteroids. , 1997, Annual review of plant biology.

[22]  Martin Wehling,et al.  Nongenomic actions of steroid hormones , 2003, Nature Reviews Molecular Cell Biology.

[23]  Li Yuan,et al.  Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes. , 2002, Chinese medical journal.

[24]  Jianming Li,et al.  BRI1/BAK1, a Receptor Kinase Pair Mediating Brassinosteroid Signaling , 2002, Cell.

[25]  Samy I McFarlane,et al.  Metformin: An Update , 2002, Annals of Internal Medicine.

[26]  T. Altmann,et al.  Analysis of carbohydrate metabolism of CPD antisense plants and the brassinosteroid-deficient cbb1 mutant , 2002 .

[27]  S. Clouse.  Brassinosteroids. Plant counterparts to animal steroid hormones? , 2002, Vitamins and hormones.

[28]  J. Chory,et al.  BRI1 is a critical component of a plasma-membrane receptor for plant steroids , 2001, Nature.

[29]  G. Mithieux,et al.  The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats. , 1999, Gastroenterology.

[30]  R. Pharis,et al.  Structure–activity studies of brassinolide B-ring analogues , 1998 .

[31]  J. Girard,et al.  Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. , 1998, Diabetes.

[32]  R. Hanson,et al.  Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. , 1997, Annual review of biochemistry.

[33]  A. Lange,et al.  Regulation of Rat Liver Glucose-6-Phosphatase Gene Expression in Different Nutritional and Hormonal States: Gene Structure and 5′-Flanking Sequence , 1996, Diabetes.

[34]  D. Schmoll,et al.  Cloning and sequencing of the 5′ region of the human glucose‐6‐phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells , 1996, FEBS letters.

[35]  J. C. Cook,et al.  Brassinolide, a plant growth-promoting steroid isolated from Brassica napus pollen , 1979, Nature.